Division of Breast Surgery, European Institute of Oncology IRCCS, Milan, Italy.
Data Management, European Institute of Oncology IRCCS, Milan, Italy.
Ann Surg. 2022 Jul 1;276(1):11-19. doi: 10.1097/SLA.0000000000004969. Epub 2021 Jun 9.
The aim of this study was to compare robotic mastectomy with open classical technique outcomes in breast cancer patients.
As the use of robotic nipple sparing mastectomy continues to rise, improved understanding of the surgical, oncologic, and quality of life outcomes is imperative for appropriate patient selection as well as to better understand indications, limits, advantages, and dangers.
In a phase III, open label, single-center, randomized controlled trial involving 80 women with breast cancer (69) or with BRCA mutation (11), we compared the outcome of robotic and open nipple sparing mastectomy. Primary outcomes were surgical complications and quality of life using specific validated questionnaires. Secondary objective included oncologic outcomes.
Robotic procedure was 1 hour and 18 minutes longer than open (P < 0.001). No differences in the number or type of complications (P = 0.11) were observed. Breast-Q scores in satisfaction with breasts, psychosocial, physical and sexual well-being were significantly higher after robotic mastectomy versus open procedure. Respect to baseline, physical and sexual well-being domains remained stable after robotic mastectomy, whereas they significantly decreased after open procedure (P < 0.02). The overall Body Image Scale questionnaire score was 20.7 ± 13.8 versus 9.9 ± 5.1 in the robotic versus open groups respectively, P < 0.0001. At median follow-up 28.6months (range 3.7-43.3), no local events were observed.
Complications were similar among groups upholding the robotic technique to be safe. Quality of life was maintained after robotic mastectomy while significantly decrease after open surgery. Early follow-up confirm no premature local failure.ClinicalTrials.gov NCT03440398.
本研究旨在比较机器人乳房切除术与乳腺癌患者开放式经典技术的结果。
随着机器人乳头保留乳房切除术的应用不断增加,对于适当的患者选择,以及更好地理解适应症、局限性、优势和风险,了解手术、肿瘤学和生活质量结果至关重要。
在一项涉及 80 名乳腺癌(69 名)或 BRCA 突变(11 名)患者的 III 期、开放性、单中心、随机对照试验中,我们比较了机器人和开放性乳头保留乳房切除术的结果。主要结果是使用特定的验证问卷评估手术并发症和生活质量。次要目标包括肿瘤学结果。
机器人手术比开放手术长 1 小时 18 分钟(P < 0.001)。并发症的数量和类型无差异(P = 0.11)。乳房 Q 评分在对乳房的满意度、心理社会、身体和性健康方面,机器人乳房切除术明显高于开放手术。与基线相比,机器人乳房切除术后身体和性健康领域保持稳定,而开放手术后显著下降(P < 0.02)。整体身体形象量表问卷评分分别为机器人组 20.7 ± 13.8,开放组 9.9 ± 5.1,P < 0.0001。中位随访 28.6 个月(范围 3.7-43.3),未观察到局部事件。
两组并发症相似,证明机器人技术安全。机器人乳房切除术后生活质量保持稳定,而开放手术后显著下降。早期随访证实无早期局部失败。ClinicalTrials.gov NCT03440398。